Skip to main content

2 Result(s)

within Licong Liang Remove this filter

and

  1. Article

    Open Access

    Tyrosine-kinase inhibitor combined with iodine-125 seed brachytherapy for hepatocellular carcinoma refractory to transarterial chemoembolization: a propensity-matched study

    To investigate the efficacy and safety of tyrosine-kinase inhibitor (TKI) combined with iodine-125 seed brachytherapy (TKI-I) versus TKI alone for patients with hepatocellular carcinoma (HCC) refractory to tra...

    Yongjian Guo, **gqiang Wu, Licong Liang, Kangshun Zhu, **gwen Zhou… in Cancer Imaging (2023)

    Download PDF (1504 KB) View Article

  2. Article

    Open Access

    Inhibition of CEMIP potentiates the effect of sorafenib on metastatic hepatocellular carcinoma by reducing the stiffness of lung metastases

    Hepatocellular carcinoma (HCC) with lung metastasis is associated with poor prognosis and poor therapeutic outcomes. Studies have demonstrated that stiffened stroma can promote metastasis in various tumors. Ho...

    Mingyu Liu, Lulu **e, Yuying Zhang, Jianning Chen, **ang Zhang… in Cell Death & Disease (2023)

    Download PDF (8311 KB) View Article